REFERENCES
- National Treatment Agency. Injectable Heroin (and Injectable Methadone)—Potential Roles in Drug Treatment. London: National Treatment Agency; 2003. Also available at www.nta.nhs.uk..
- Stimson GV, Metrebian N. Prescribing Heroin. York, UK: Joseph Rowntree Foundation;2003.
- Hartnoll RL, Mitcheson MC, Battersby A, , et al. Evaluation of heroin maintenance in a controlled trial. Arch Gen Psychiatry 1980;37:877–884. [PUBMED], [INFOTRIEVE], [CSA]
- Strang J, Sheridan J. Heroin prescribing in the “British System” of the mid 1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug and Alcohol Reviews 1997;16:7–16. [CSA]
- Strang J, Sheridan J, Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ 1996;313:270–272. [PUBMED], [INFOTRIEVE], [CSA]
- Metrebian N, Carnwath T, Stimson GV, Storz T. Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction 2002;97:1155–1161. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zador D. Injectable opiate maintenance in the UK: is it good clinical practice? Addiction 2001;96:547–553. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blattler R, Pfeiffer S. Prescription of Narcotics for Heroin Addicts: Main Results of the Swiss National Cohort Study. Basel: Karger;1999.
- van den Brink W, Vincent M, Hendriks VM, Blanken P, Huijsman IA, van Ree JN. Medical Co-Prescription of Heroin: Two Randomized Controlled Trials. >Utrecht: Central Committee on The Treatment of Heroin Addicts; 2002. Also available at www.ccbh.nl..
- McCusker C, Davies M. Prescribing drug of choice to illicit heroin users: the experience of a UK community drug team. J Subst Abuse Treat. 1996;13:521–531. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perneger TV, Giner F, del Rio M, Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998;317:13–18. [PUBMED], [INFOTRIEVE], [CSA]
- Ali R, Auriacombe M, Casas M, , et al. Report of the External Panel on the Evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts. >Geneva: World Health Organization; 1999.
- Reed LJ, de Wet C, Bearn J. Prescription of heroin to treatment resistant heroin addicts: replacement therapies need to be tested on a level playing field. BMJ 2004;328:228. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Caplehorn J. Prescription of heroin to treatment resistant heroin addicts: Dutch heroin trials show retention is better with methadone alone. BMJ 2004;328:228–229. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dehue T. Prescription of heroin to treatment resistant heroin addicts: double blinding is not possible. BMJ 2004;328:228. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van den Brink W, Blanken P, Hendriks VM. Prescription of heroin to treatment resistant heroin addicts: authors' reply. BMJ 2004;328:229. [CSA], [CROSSREF]
- Metrebian N, Shanahan W, Stimson GV, , et al. Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug and Alcohol Reviews 2001;20:267–276. [CSA], [CROSSREF]
- Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Diffusion of benefit through Syringe Exchange Study Team: sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 2004;99:1136–1146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stopka TJ, Singer M, Santelices C, Eiserman J. Public health interventionists, penny capitalists, or sources of risk?: assessing street syringe sellers in Hartford, Connecticut. Subst Use Misuse. 2003;38:1345–1377. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McKeganey N, Morris Z, Neale J, Robertson M. What are drug users looking for when they contact drug services: abstinence or harm reduction? Drugs: Education, Prevention and Policy. 2005;11:423–453. [CSA]
- Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs 2002;62:1331–1343. [PUBMED], [INFOTRIEVE], [CSA]
- Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 2005;100:150–158. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Auriacombe M, Fatseas M, Dubernet J, Daulouede JP, Tignol J. French field experience with buprenorphine. Am J Addict. 2004;13 Suppl 1:S17–S28. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]